Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Nephrol Dial Transplant
Hoofdauteurs: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
CLINICAL SCIENCE
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://ncbi.nlm.nih.gov/pubmed/26429974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items